{"disease":{"id":"fh-deficient","name":"fh deficient"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05535829","title":"Molecular Markers in Predicting Response to Treatment in FH-deficient RCC Patients","phase":"","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"RenJi Hospital","has_results":false},{"nct_id":"NCT04146831","title":"Sintilimab in FH-deficient Renal Cell Carcinoma","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":37,"lead_sponsor_name":"West China Hospital","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}